Compendium of Cancer Genome Aberrations

Changes

HAEM5:Volunteer Assignments and Opportunities (view source)

Revision as of 00:17, 24 December 2023

3,875 bytes added ,  00:17, 24 December 2023
no edit summary
Line 1,890: Line 1,890:  
|
 
|
 
|-
 
|-
−
|Burkitt lymphoma||Disease||PENDING
+
|[[HAEM5:Burkitt lymphoma|Burkitt lymphoma]]||Disease||PENDING
 
| || || || ||GC|| ||
 
| || || || ||GC|| ||
 
|Burkitt Lymphoma
 
|Burkitt Lymphoma
Line 1,898: Line 1,898:  
|
 
|
 
|-
 
|-
−
|Primary effusion lymphoma||Disease|| || || || || ||GC|| ||
+
|[[HAEM5:Primary effusion lymphoma|Primary effusion lymphoma]]||Disease|| || || || || ||GC|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 1,905: Line 1,905:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|KSHV/HHV8-positive diffuse large B-cell lymphoma||Disease|| || || || || ||GC|| ||
+
|[[HAEM5:KSHV/HHV8-positive diffuse large B-cell lymphoma|KSHV/HHV8-positive diffuse large B-cell lymphoma]]||Disease|| || || || || ||GC|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 1,912: Line 1,912:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|KSHV/HHV8-positive germinotropic lymphoproliferative disorder||Disease|| || || || || ||GC|| ||
+
|[[HAEM5:KSHV/HHV8-positive germinotropic lymphoproliferative disorder|KSHV/HHV8-positive germinotropic lymphoproliferative disorder]]||Disease|| || || || || ||GC|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 1,919: Line 1,919:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Hyperplasias arising in immune deficiency/dysregulation||Disease||FIX ISSUE! (on 5th edition page instructions say "encompassing non-destructive post-transplant lymphoproliferative disorders, among others")|| || || || ||GC|| ||
+
|[[HAEM5:Hyperplasias arising in immune deficiency/dysregulation|Hyperplasias arising in immune deficiency/dysregulation]]||Disease||FIX ISSUE! (on 5th edition page instructions say "encompassing non-destructive post-transplant lymphoproliferative disorders, among others")|| || || || ||GC|| ||
 
|
 
|
 
|
 
|
Line 1,926: Line 1,926:  
|
 
|
 
|-
 
|-
−
|Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation||Disease||FIX ISSUE! (on 5th edition page instructions say "This page was converted to the new template on 2023-12-07. The original page can be found at [[HAEM4:Polymorphic Post-Transplant Lymphoproliferative Disorders]].
+
|[[HAEM5:Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation|Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation]]||Disease||FIX ISSUE! (on 5th edition page instructions say "This page was converted to the new template on 2023-12-07. The original page can be found at [[HAEM4:Polymorphic Post-Transplant Lymphoproliferative Disorders]].
 
Note: encompassing polymorphic PTLD, other iatrogenic immunodef-assoc lympho disorders, among others)"
 
Note: encompassing polymorphic PTLD, other iatrogenic immunodef-assoc lympho disorders, among others)"
 
| || || || ||GC|| ||
 
| || || || ||GC|| ||
Line 1,935: Line 1,935:  
|
 
|
 
|-
 
|-
−
|EBV-positive mucocutaneous ulcer||Disease|| || || || || ||GC|| ||
+
|[[HAEM5:EBV-positive mucocutaneous ulcer|EBV-positive mucocutaneous ulcer]]||Disease|| || || || || ||GC|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 1,942: Line 1,942:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Lymphomas arising in immune deficiency / dysregulation||Disease||FIX ISSUE! (on 5th edition page instructions say "encompassing monomorphic PTLD, classic HL PTLD, lymphomas assoc with HIV infection, among others"|| || || || ||GC|| ||
+
|[[HAEM5:Lymphomas arising in immune deficiency / dysregulation|Lymphomas arising in immune deficiency / dysregulation]]||Disease||FIX ISSUE! (on 5th edition page instructions say "encompassing monomorphic PTLD, classic HL PTLD, lymphomas assoc with HIV infection, among others"|| || || || ||GC|| ||
 
|
 
|
 
|
 
|
Line 1,949: Line 1,949:  
|
 
|
 
|-
 
|-
−
|Inborn error of immunity-associated lymphoid proliferations and lymphomas||Disease||FIX ISSUE! (on 5th edition page instructions say "Editor said this overview page is a match. [Immunodeficiency-Associated Lymphoproliferative Disorders] [Lymphoproliferative diseases associated with primary immune disorders]")|| || || || ||GC|| ||
+
|[[HAEM5:Inborn error of immunity-associated lymphoid proliferations and lymphomas|Inborn error of immunity-associated lymphoid proliferations and lymphomas]]||Disease||FIX ISSUE! (on 5th edition page instructions say "Editor said this overview page is a match. [Immunodeficiency-Associated Lymphoproliferative Disorders] [Lymphoproliferative diseases associated with primary immune disorders]")|| || || || ||GC|| ||
 
|
 
|
 
|
 
|
Line 1,956: Line 1,956:  
|
 
|
 
|-
 
|-
−
|Classic Hodgkin lymphoma||Disease||PENDING
+
|[[HAEM5:Classic Hodgkin lymphoma|Classic Hodgkin lymphoma]]||Disease||PENDING
 
| || || ||Note: author needs to merge Nodular Sclerosis Classic Hodgkin Lymphoma, Lymphocyte-Rich Classic Hodgkin Lymphoma, Mixed Cellularity Classic Hodgkin Lymphoma, Lymphocyte-Depleted Classic Hodgkin Lymphoma
 
| || || ||Note: author needs to merge Nodular Sclerosis Classic Hodgkin Lymphoma, Lymphocyte-Rich Classic Hodgkin Lymphoma, Mixed Cellularity Classic Hodgkin Lymphoma, Lymphocyte-Depleted Classic Hodgkin Lymphoma
 
|GC|| ||
 
|GC|| ||
Line 1,965: Line 1,965:  
|
 
|
 
|-
 
|-
−
|Nodular lymphocyte predominant Hodgkin lymphoma||Disease|| || || || || ||GC|| ||
+
|[[HAEM5:Nodular lymphocyte predominant Hodgkin lymphoma|Nodular lymphocyte predominant Hodgkin lymphoma]]||Disease|| || || || || ||GC|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 1,972: Line 1,972:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Cold agglutinin disease
+
|[[HAEM5:Cold agglutinin disease|Cold agglutinin disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,988: Line 1,988:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
+
|[[HAEM5:IgM monoclonal gammopathy of undetermined significance|IgM monoclonal gammopathy of undetermined significance]]||Disease|| || || || || ||SG|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 1,995: Line 1,995:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
+
|[[HAEM5:Non-IgM monoclonal gammopathy of undetermined significance|Non-IgM monoclonal gammopathy of undetermined significance]]||Disease|| || || || || ||SG|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,002: Line 2,002:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG
+
|[[HAEM5:Monoclonal gammopathy of renal significance|Monoclonal gammopathy of renal significance]]||Disease|| || || || || ||SG
 
| ||
 
| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,010: Line 2,010:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Immunoglobulin-related (AL) amyloidosis||Disease||PENDING
+
|[[HAEM5:Immunoglobulin-related (AL) amyloidosis|Immunoglobulin-related (AL) amyloidosis]]||Disease||PENDING
 
| || || || ||SG
 
| || || || ||SG
 
| ||
 
| ||
Line 2,019: Line 2,019:  
|
 
|
 
|-
 
|-
−
|Monoclonal immunoglobulin deposition disease||Disease||PENDING
+
|[[HAEM5:Monoclonal immunoglobulin deposition disease|Monoclonal immunoglobulin deposition disease]]||Disease||PENDING
 
| || || || ||SG
 
| || || || ||SG
 
| ||
 
| ||
Line 2,028: Line 2,028:  
|
 
|
 
|-
 
|-
−
|Mu heavy chain disease||Disease|| || || || || ||SG
+
|[[HAEM5:Mu heavy chain disease|Mu heavy chain disease]]||Disease|| || || || || ||SG
 
| ||
 
| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,036: Line 2,036:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Gamma heavy chain disease||Disease||PENDING
+
|[[HAEM5:Gamma heavy chain disease|Gamma heavy chain disease]]||Disease||PENDING
 
| || || || ||SG
 
| || || || ||SG
 
| ||
 
| ||
Line 2,045: Line 2,045:  
|
 
|
 
|-
 
|-
−
|Alpha heavy chain disease||Disease|| || || || || ||SG
+
|[[HAEM5:Alpha heavy chain disease|Alpha heavy chain disease]]||Disease|| || || || || ||SG
 
| ||
 
| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,053: Line 2,053:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Plasmacytoma||Disease||PENDING
+
|[[HAEM5:Plasmacytoma|Plasmacytoma]]||Disease||PENDING
 
| || || ||author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga)
 
| || || ||author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga)
 
|SG
 
|SG
Line 2,063: Line 2,063:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Plasma cell myeloma / multiple myeloma||Disease||PENDING
+
|[[HAEM5:Plasma cell myeloma / multiple myeloma|Plasma cell myeloma / multiple myeloma]]||Disease||PENDING
 
| || || ||Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page||SG
 
| || || ||Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page||SG
 
| ||
 
| ||
Line 2,072: Line 2,072:  
|
 
|
 
|-
 
|-
−
|Plasma cell neoplasms with associated paraneoplastic syndrome||Disease||PENDING
+
|[[HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome|Plasma cell neoplasms with associated paraneoplastic syndrome]]||Disease||PENDING
 
| || || ||Note: author needs to include POEMS, TEMPI, and look for AESOP content
 
| || || ||Note: author needs to include POEMS, TEMPI, and look for AESOP content
 
|SG
 
|SG
Line 2,112: Line 2,112:  
----<br />
 
----<br />
 
|-
 
|-
−
|Kikuchi-Fujimoto disease||Disease|| || || || || ||Sumi Kitahara (SK)
+
|[[HAEM5:Kikuchi-Fujimoto disease|Kikuchi-Fujimoto disease]]||Disease|| || || || || ||Sumi Kitahara (SK)
 
| ||
 
| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,120: Line 2,120:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Autoimmune lymphoproliferative syndrome||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Autoimmune lymphoproliferative syndrome|Autoimmune lymphoproliferative syndrome]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,127: Line 2,127:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Indolent T-lymphoblastic proliferation||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Indolent T-lymphoblastic proliferation|Indolent T-lymphoblastic proliferation]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,134: Line 2,134:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|T-lymphoblastic leukaemia / lymphoma, NOS||Disease|| || || || || ||HD|| ||
+
|[[HAEM5:T-lymphoblastic leukaemia / lymphoma, NOS|T-lymphoblastic leukaemia / lymphoma, NOS]]||Disease|| || || || || ||HD|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,141: Line 2,141:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Early T-precursor lymphoblastic leukaemia / lymphoma
+
|[[HAEM5:Early T-precursor lymphoblastic leukaemia / lymphoma|Early T-precursor lymphoblastic leukaemia / lymphoma]]
 
|Disease
 
|Disease
 
|PENDING
 
|PENDING
Line 2,157: Line 2,157:  
|
 
|
 
|-
 
|-
−
|T-prolymphocytic leukaemia
+
|[[HAEM5:T-prolymphocytic leukaemia|T-prolymphocytic leukaemia]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,173: Line 2,173:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|T-large granular lymphocytic leukaemia||Disease||PENDING
+
|[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|T-cell Large Granular Lymphocytic Leukemia
 
|T-cell Large Granular Lymphocytic Leukemia
Line 2,181: Line 2,181:  
|
 
|
 
|-
 
|-
−
|NK-large granular lymphocytic leukaemia||Disease||PENDING
+
|[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Chronic Lymphoproliferative Disorder of NK Cells
 
|Chronic Lymphoproliferative Disorder of NK Cells
Line 2,189: Line 2,189:  
|
 
|
 
|-
 
|-
−
|Adult T-cell leukaemia/lymphoma||Disease||PENDING
+
|[[HAEM5:Adult T-cell leukaemia/lymphoma|Adult T-cell leukaemia/lymphoma]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Adult T-cell Leukemia/Lymphoma
 
|Adult T-cell Leukemia/Lymphoma
Line 2,197: Line 2,197:  
|
 
|
 
|-
 
|-
−
|Sezary syndrome||Disease||PENDING
+
|[[HAEM5:Sezary syndrome|Sezary syndrome]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Sézary Syndrome
 
|Sézary Syndrome
Line 2,205: Line 2,205:  
|
 
|
 
|-
 
|-
−
|Aggressive NK-cell leukaemia||Disease||PENDING
+
|[[HAEM5:Aggressive NK-cell leukaemia|Aggressive NK-cell leukaemia]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Aggressive NK-cell Leukemia
 
|Aggressive NK-cell Leukemia
Line 2,213: Line 2,213:  
|
 
|
 
|-
 
|-
−
|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,220: Line 2,220:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder|Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,227: Line 2,227:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Mycosis fungoides||Disease||PENDING
+
|[[HAEM5:Mycosis fungoides|Mycosis fungoides]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Mycosis Fungoides
 
|Mycosis Fungoides
Line 2,235: Line 2,235:  
|
 
|
 
|-
 
|-
−
|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,242: Line 2,242:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma||Disease||PENDING
+
|[[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Primary Cutaneous Anaplastic Large Cell Lymphoma
 
|Primary Cutaneous Anaplastic Large Cell Lymphoma
Line 2,250: Line 2,250:  
|
 
|
 
|-
 
|-
−
|Subcutaneous panniculitis-like T-cell lymphoma||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Subcutaneous panniculitis-like T-cell lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,257: Line 2,257:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Primary cutaneous gamma/delta T-cell lymphoma||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Primary cutaneous gamma/delta T-cell lymphoma|Primary cutaneous gamma/delta T-cell lymphoma]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,264: Line 2,264:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma|Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,271: Line 2,271:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Primary cutaneous peripheral T-cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Primary cutaneous peripheral T-cell lymphoma, NOS|Primary cutaneous peripheral T-cell lymphoma, NOS]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,278: Line 2,278:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Indolent T-cell lymphoma of the gastrointestinal tract||Disease||PENDING
+
|[[HAEM5:Indolent T-cell lymphoma of the gastrointestinal tract|Indolent T-cell lymphoma of the gastrointestinal tract]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
 
|Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
Line 2,286: Line 2,286:  
|
 
|
 
|-
 
|-
−
|Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract|Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,293: Line 2,293:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Enteropathy-associated T-cell lymphoma||Disease||PENDING
+
|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Enteropathy-Associated T-cell Lymphoma
 
|Enteropathy-Associated T-cell Lymphoma
Line 2,301: Line 2,301:  
|
 
|
 
|-
 
|-
−
|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease||PENDING
+
|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
 
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
Line 2,309: Line 2,309:  
|
 
|
 
|-
 
|-
−
|Intestinal T-cell lymphoma, NOS||Disease||PENDING
+
|[[HAEM5:Intestinal T-cell lymphoma, NOS|Intestinal T-cell lymphoma, NOS]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
 
|Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
Line 2,317: Line 2,317:  
|
 
|
 
|-
 
|-
−
|Hepatosplenic T-cell lymphoma||Disease||PENDING
+
|[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Hepatosplenic T-cell Lymphoma
 
|Hepatosplenic T-cell Lymphoma
Line 2,325: Line 2,325:  
|
 
|
 
|-
 
|-
−
|ALK-positive anaplastic large cell lymphoma||Disease||PENDING
+
|[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Anaplastic Large Cell Lymphoma, ALK-Positive
 
|Anaplastic Large Cell Lymphoma, ALK-Positive
Line 2,337: Line 2,337:  
|
 
|
 
|-
 
|-
−
|ALK-negative anaplastic large cell lymphoma||Disease||PENDING
+
|[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Anaplastic Large Cell Lymphoma, ALK-Negative
 
|Anaplastic Large Cell Lymphoma, ALK-Negative
Line 2,345: Line 2,345:  
|
 
|
 
|-
 
|-
−
|Breast implant-associated anaplastic large cell lymphoma||Disease||PENDING
+
|[[HAEM5:Breast implant-associated anaplastic large cell lymphoma|Breast implant-associated anaplastic large cell lymphoma]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma
Line 2,353: Line 2,353:  
|
 
|
 
|-
 
|-
−
|Nodal TFH cell lymphoma, angioimmunoblastic-type||Disease||Issue - Rachel Burnside was working on this. Note says: "has prior content and name will change in 5th edition - Rachel working on this outside of production site to be replaced later by Nodal TFH Cell Lymphoma, Angioimmunoblastic-Type)". Where is her content as previous author names on 5th edition page||7/28/2023
+
|[[HAEM5:Nodal TFH cell lymphoma, angioimmunoblastic-type|Nodal TFH cell lymphoma, angioimmunoblastic-type]]||Disease||Issue - Rachel Burnside was working on this. Note says: "has prior content and name will change in 5th edition - Rachel working on this outside of production site to be replaced later by Nodal TFH Cell Lymphoma, Angioimmunoblastic-Type)". Where is her content as previous author names on 5th edition page||7/28/2023
 
| ||Pending|| ||SK|| ||
 
| ||Pending|| ||SK|| ||
 
|Angioimmunoblastic T-cell Lymphoma
 
|Angioimmunoblastic T-cell Lymphoma
Line 2,361: Line 2,361:  
|
 
|
 
|-
 
|-
−
|Nodal TFH cell lymphoma, follicular-type||Disease||Rachel Burnside||7/28/2023
+
|[[HAEM5:Nodal TFH cell lymphoma, follicular-type|Nodal TFH cell lymphoma, follicular-type]]||Disease||Rachel Burnside||7/28/2023
 
| ||Pending|| ||SK|| ||
 
| ||Pending|| ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,369: Line 2,369:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Nodal TFH cell lymphoma, NOS||Disease||PENDING
+
|[[HAEM5:Nodal TFH cell lymphoma, NOS|Nodal TFH cell lymphoma, NOS]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype
 
|Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype
Line 2,377: Line 2,377:  
|
 
|
 
|-
 
|-
−
|Peripheral T-cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Peripheral T-cell lymphoma, NOS|Peripheral T-cell lymphoma, NOS]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,384: Line 2,384:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|EBV-positive nodal T- and NK-cell lymphoma||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,391: Line 2,391:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Extranodal NK/T-cell lymphoma||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Extranodal NK/T-cell lymphoma|Extranodal NK/T-cell lymphoma]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,398: Line 2,398:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Severe mosquito bite allergy||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Severe mosquito bite allergy|Severe mosquito bite allergy]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,405: Line 2,405:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Hydroa vacciniforme lymphoproliferative disorder||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Hydroa vacciniforme lymphoproliferative disorder|Hydroa vacciniforme lymphoproliferative disorder]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,412: Line 2,412:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Systemic chronic active EBV disease||Disease|| || || || || ||SK|| ||
+
|[[HAEM5:Systemic chronic active EBV disease|Systemic chronic active EBV disease]]||Disease|| || || || || ||SK|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,419: Line 2,419:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Systemic EBV-positive T-cell lymphoma of childhood||Disease||PENDING
+
|[[HAEM5:Systemic EBV-positive T-cell lymphoma of childhood|Systemic EBV-positive T-cell lymphoma of childhood]]||Disease||PENDING
 
| || || || ||SK|| ||
 
| || || || ||SK|| ||
 
|Systemic EBV-Positive T-cell Lymphoma of Childhood
 
|Systemic EBV-Positive T-cell Lymphoma of Childhood
Line 2,457: Line 2,457:  
----<br />
 
----<br />
 
|-
 
|-
−
|Follicular dendritic cell sarcoma
+
|[[HAEM5:Follicular dendritic cell sarcoma|Follicular dendritic cell sarcoma]]
 
|Disease
 
|Disease
 
|PENDING
 
|PENDING
Line 2,473: Line 2,473:  
|
 
|
 
|-
 
|-
−
|EBV-positive inflammatory follicular dendritic cell sarcoma
+
|[[HAEM5:EBV-positive inflammatory follicular dendritic cell sarcoma|EBV-positive inflammatory follicular dendritic cell sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,489: Line 2,489:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Fibroblastic reticular cell tumour
+
|[[HAEM5:Fibroblastic reticular cell tumour|Fibroblastic reticular cell tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,505: Line 2,505:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Intranodal palisaded myofibroblastoma
+
|[[HAEM5:Intranodal palisaded myofibroblastoma|Intranodal palisaded myofibroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,521: Line 2,521:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Littoral cell angioma
+
|[[HAEM5:Littoral cell angioma|Littoral cell angioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,537: Line 2,537:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Splenic hamartoma
+
|[[HAEM5:Splenic hamartoma|Splenic hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,553: Line 2,553:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Sclerosing angiomatoid nodular transformation (SANT) of spleen
+
|[[HAEM5:Sclerosing angiomatoid nodular transformation (SANT) of spleen|Sclerosing angiomatoid nodular transformation (SANT) of spleen]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,599: Line 2,599:  
----<br />
 
----<br />
 
|-
 
|-
−
|Fanconi anaemia||Disease|| || || || || ||NA|| ||
+
|[[HAEM5:Fanconi anaemia|Fanconi anaemia]]||Disease|| || || || || ||NA|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,606: Line 2,606:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Bloom syndrome||Disease|| || || || || ||NA|| ||
+
|[[HAEM5:Bloom syndrome|Bloom syndrome]]||Disease|| || || || || ||NA|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,613: Line 2,613:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Ataxia-telangiectasia syndrome||Disease|| || || || || ||NA|| ||
+
|[[HAEM5:Ataxia-telangiectasia syndrome|Ataxia-telangiectasia syndrome]]||Disease|| || || || || ||NA|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 2,620: Line 2,620:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|RASopathies||Disease|| || || || || ||NA|| ||
+
|[[HAEM5:RASopathies|RASopathies]]||Disease|| || || || || ||NA|| ||
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14012"